A new report from the ABPI and Vermilion Life Sciences examines the challenges and changes needed for the UK to lead reengineering medicines development, and proposes a new methodology to achieve this.Read more
On 7 January 2015, the National Institute for Health and Care Excellence (NICE) issued a draft clinical practice guideline on the management of type 2 diabetes by the NHS in England and Wales. The Association of the British Pharmaceutical Industry (ABPI) welcomes the opportunity to respond to the draft guidelines.Read more
The ABPI and NHS England have launched a series of roadshows to improve patient outcomes through the benefits of Pharmaceutical Price Regulation Scheme (PPRS) and medicines optimisation. Read more
The Association of the British Pharmaceutical Industry (ABPI) welcomes its newest member Santen UK.Read more
Our website is not compatible with Internet Explorer 8. If you are experiencing problems with scrolling please upgrade to a later version or use another browser.